FDA clearance references the underlying autonomic diagnostic protocol delivered through the clinic-based device first cleared by FDA in 1995 (510(k) pathway), commercially launched in the industry by Autonomic Health's Chief Medical Officer in 2006. CloudANS™ and the at-home wearable version run the same protocol; they are not separately FDA-cleared.
© 2026 Autonomic HealthHIPAA compliantClinically Validated